Lawrence J. Gelb

Vice President - Global Ehs, Security, & Business Continuity - Cytiva (a Danaher Opco) at Cytiva

Lawrence J. Gelb has extensive work experience in various industries and roles. Lawrence J. is currently the Vice President of Global EHS, Security, and Business Continuity at Cytiva, where they lead the functions across multiple sectors and locations. Prior to this, Gelb held multiple positions at Danaher Corporation, including Vice President of Global EHS, Facilities, and Sustainability at Pall Life Sciences, where they implemented successful strategies and initiatives. Before joining Danaher, Gelb worked at Bausch Health Companies Inc. and Bausch & Lomb, Inc., managing global sustainability and directing environmental, health, and safety activities. Lawrence J. also has experience at Princess House, HJ Heinz/Starkist Foods, and Sandvik in various EHS and management roles.

Lawrence J. Gelb has a Master of Liberal Arts (ALM) in Environmental Management & Sustainability from Harvard University. Lawrence J. also obtained a BSc in Safety Science from Indiana University of Pennsylvania. Gelb has a Post Baccalaureate Professional Graduate Certificate in Sustainability from Harvard Extension School, as well as completed Center for Continuing Professional Education Courses in EHS Leadership / Ergonomics from Harvard T.H. Chan School of Public Health. Lawrence J. holds a StrategyEx Professional Continuing Education Certificate in Project Management from The George Washington University School of Business. Gelb attended Wyoming Valley West H.S. for their high school education. In terms of additional certifications, Gelb is a Danaher Business System (DBS) - EHS 4E Tool - Certified Practitioner certified by Danaher Corporation and is a LEED Accredited Professional (ID+C) certified by the Green Building Certification Institute (GBCI).

Links

Previous companies

Sandvik logo
Danaher logo
Kraft Heinz logo
Bausch Health Companies logo

Timeline

  • Vice President - Global Ehs, Security, & Business Continuity - Cytiva (a Danaher Opco)

    May, 2023 - present